191 related articles for article (PubMed ID: 37547760)
1. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract][Full Text] [Related]
2. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
3. The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
Wei Y; Chen Z; Li Y; Song K
Oncogene; 2024 May; 43(20):1565-1578. PubMed ID: 38561505
[TBL] [Abstract][Full Text] [Related]
4. SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
Zhou J; Chen W; He Q; Chen D; Li C; Jiang C; Ding Z; Qian Q
PeerJ; 2022; 10():e14084. PubMed ID: 36213507
[TBL] [Abstract][Full Text] [Related]
5. Transformer 2β homolog (Drosophila) (TRA2B) regulates protein kinase C δI (PKCδI) splice variant expression during 3T3L1 preadipocyte cell cycle.
Patel RS; Carter G; Cooper DR; Apostolatos H; Patel NA
J Biol Chem; 2014 Nov; 289(46):31662-31672. PubMed ID: 25261467
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
He C; Huang F; Zhang K; Wei J; Hu K; Liang M
J Ovarian Res; 2021 Feb; 14(1):27. PubMed ID: 33550985
[TBL] [Abstract][Full Text] [Related]
7. ATP5A1 Participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated Genes by Modulating Their Expression and Alternative Splicing Profiles in HeLa Cells.
Song Ba Y; Wang Ma F; Wei Ma Y; Chen Ba D; Deng Ba G
Technol Cancer Res Treat; 2021; 20():15330338211039126. PubMed ID: 34520292
[No Abstract] [Full Text] [Related]
8. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
Zhuang RJ; Bai XX; Liu W
Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
[TBL] [Abstract][Full Text] [Related]
9. SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52.
Diao Y; Li Y; Wang Z; Wang S; Li P; Kong B
Cell Death Dis; 2022 Feb; 13(2):179. PubMed ID: 35210412
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
11. HnRNPA1 interacts with G-quadruplex in the TRA2B promoter and stimulates its transcription in human colon cancer cells.
Nishikawa T; Kuwano Y; Takahara Y; Nishida K; Rokutan K
Sci Rep; 2019 Jul; 9(1):10276. PubMed ID: 31311954
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
13. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
[TBL] [Abstract][Full Text] [Related]
14. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
Wu D; Liu C; Hong L
Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
[TBL] [Abstract][Full Text] [Related]
15. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
Wang L; He M; Fu L; Jin Y
Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
[TBL] [Abstract][Full Text] [Related]
16. The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer.
Zhong Y; Yang S; Wang W; Wei P; He S; Ma H; Yang J; Wang Q; Cao L; Xiong W; Zhou M; Li G; Shuai C; Peng S
Oncogene; 2019 Feb; 38(9):1381-1397. PubMed ID: 30266988
[TBL] [Abstract][Full Text] [Related]
17. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
Li W; Ma S; Bai X; Pan W; Ai L; Tan W
J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
[TBL] [Abstract][Full Text] [Related]
19. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-204-5p Inhibits Ovarian Cancer Cell Proliferation by Down-Regulating USP47.
Hu L; Kolibaba H; Zhang S; Cao M; Niu H; Mei H; Hao Y; Xu Y; Yin Q
Cell Transplant; 2019 Dec; 28(1_suppl):51S-58S. PubMed ID: 31526052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
